Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

Pfizer Admits Its COVID-19 Pill Doesn’t Work for Healthier Patients With Standard Risk

Pfizer plans to stop enrollment in a study of its COVID-19 pill for patients with standard risk for developing severe disease after it failed to lower their risk of hospitalization or death.

The drugmaker said Tuesday (June 14) that it would stop adding new patients to the study testing Paxlovid in COVID-19 patients who were either unvaccinated or fully vaccinated with at least one medical condition that increased their risk of severe illness. The company said it will continue to evaluate the treatment in patients with high unmet need.

Last December, Pfizer reported early data from the study showing that Paxlovid didn’t reduce the risk of hospitalization or death in a way that was statistically significant.

    Joe Biden: Pandemic is Over

    Joe Biden during an interview on 60Minutes says he believes the COVID pandemic is Over. 850 more unvaxxed NYC teachers, aides fired for not complying

    Lockdowns Harms Impossible to Cover Up

    “According to a recent study by the World Bank, published in the journal Nature, lockdowns and the response to Covid-19 have pushed an additional 75

    Contagious Vaccines: A Warning

    Brownstone Institute – For two decades scientists have been quietly developing self-spreading contagious vaccines. The NIH funded this research, in which either DNA from a deadly

    VAERS Reports as of 6/10/2022 Release

    28,859 Deaths where Vaccine is COVID19 1,301,356 Adverse Events where Vaccine is COVID19 Search Vaccine Reactions Using MedAlertsA Powerful VAERS Database Search Engine hosted by

    Would love your thoughts, please comment.x

    Get in Touch!

    Purpose of your Contact
    Where can i reach you?
    What would you like to discuss?

    Are you intending to visit the Lorphic marketing agency?